← Open Payments lookup

SUSAN ZEMITIS: Open Payments

NPI 1093483505 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,831 in 125 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,607 · 2025 $2,831

Food & beverage: $2,831
CompanyPaymentsAmount
Gilead Sciences, Inc.16$385
ABBVIE INC.21$367
Ardelyx, Inc.19$345
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$312
PFIZER INC.8$168
Ipsen Biopharmaceuticals, Inc7$152
Novo Nordisk Inc2$141
Takeda Pharmaceuticals U.S.A., Inc.6$135
Ethicon US, LLC1$130
Lilly USA, LLC4$100

Products named: IBSRELA, XIFAXAN, RINVOQ, IQIRVO, Wegovy, ENTYVIO, LINX REFLUX MANAGEMENT SYSTEM, DUPIXENT.

Industry payments across VA — which companies pay providers there.